Sara Aquino
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
A nationwide Italian GIMEMA survey on tandem autologous stem cell transplantation for newly diagnosed multiple myeloma patients treated with daratumumab, bortezomib, thalidomide and dexamethasone.
Journal: Haematologica
Published: November 17, 2025
Clinicians' Perspectives and Methodological Application of Fluorescence in situ Hybridization (FISH) to Define Cytogenetic Risk in Multiple Myeloma: An Italian, Real-World, Survey-Based Report From the European Myeloma Network (EMN) Italy.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 20, 2025
Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomide-dexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data.
Journal: Haematologica
Published: January 07, 2025
Anti-BCMA CAR-T cell-based therapies and bispecific antibodies in the immunotherapy era: are we ready for this?
Journal: Expert review of hematology
Published: May 21, 2024
NAD+ metabolism restriction boosts high-dose melphalan efficacy in patients with multiple myeloma.
Journal: Blood advances
Published: April 17, 2024
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents.
Journal: Antioxidants (Basel, Switzerland)
Published: December 28, 2022
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders.
Journal: British journal of haematology
Published: December 02, 2022
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 14, 2021
Last Updated: 09/26/2026